
Opinion|Videos|October 16, 2024
Challenges Associated With Friedreich Ataxia
Author(s)Sub Subramony, M.D.
Key Takeaways
- Friedreich ataxia patients struggle with timely diagnosis and access to specialized care due to the disease's rarity and complexity.
- Families and caregivers experience significant emotional and financial burdens, managing complex care needs and providing continuous support.
Sub Subramony, M.D., discusses the challenges faced by patients with Friedreich ataxia in accessing healthcare services and managing their condition, as well as the significant burden the disease places on families and caregivers.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What are some of the challenges faced by patients with Friedreich ataxia in accessing health care services and managing their condition?
- Can you describe the burden of this disease that goes beyond the patient (eg, families and caregivers)?
Advertisement
Related to this article

Full INTerpath-001 results show the individualized mRNA therapy plus pembrolizumab reduced recurrence risk in resected stage IIB-IV melanoma.

Kidney Week 2026 abstracts show that AMKD progresses quickly in routine practice, with or without diabetes, despite background CKD therapy.

Insurance barriers were the top reason 4 in 10 people prescribed long-acting PrEP at a Missouri clinic never received it, an IDWeek 2026 poster found.

A retrospective study suggests strength exercise may be a safer option than endurance exercise for some people with ACM.

Infant flu protection from maternal vaccination varied by timing, while pediatric vaccination fell to 49.4%, experts report at IDWeek 2026.

The NCCN’s latest esophageal/EGJ guidance raises durvalumab plus FLOT to a category 2A recommendation for PD-L1–negative, diffuse-type disease.

Legal and clinical experts examined the US medical aid in dying framework, its limits, and ethical debates.
Advertisement
Advertisement
Trending on AJMC
1
Bepirovirsen Approval Offers New Option for Chronic HBV Treatment
2
Inhaled Amikacin Raises Culture Conversion in New MAC Lung Disease
3
Bronchiectasis GWAS Highlights Candidate Targets Shared With COPD
4
Uninsured Rate Rises to 11.2% as Coverage Erodes Before Medicaid Cuts
5


